Viewing Study NCT00673569


Ignite Creation Date: 2025-12-24 @ 10:52 PM
Ignite Modification Date: 2026-05-29 @ 12:10 PM
Study NCT ID: NCT00673569
Status: COMPLETED
Last Update Posted: 2010-08-09
First Post: 2008-05-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous Treatment
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent non-small cell lung cancer View
None stage IV non-small cell lung cancer View
None stage IIIA non-small cell lung cancer View
None stage IIIB non-small cell lung cancer View